ReproCELL Incorporated (TYO:4978)
Japan · Delayed Price · Currency is JPY 180.00
-3.00 (-1.64%)
Apr 17, 2026, 3:30 PM JST
ReproCELL Market Cap
ReproCELL has a market cap or net worth of 17.11 billion as of April 17, 2026. Its market cap has increased by 20.42% in one year.
Market Cap
17.11B
Enterprise Value
10.26B
Revenue
2.52B
Ranking
n/a
PE Ratio
n/a
Stock Price
180.00
Market Cap Chart
Since June 27, 2013, ReproCELL's market cap has decreased from 145.35B to 17.11B, a decrease of -88.23%. That is a compound annual growth rate of -15.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 17.11B | 29.04% |
| Dec 30, 2025 | 13.26B | 35.27% |
| Dec 30, 2024 | 9.80B | -34.19% |
| Dec 29, 2023 | 14.89B | -42.13% |
| Dec 30, 2022 | 25.73B | 35.26% |
| Dec 30, 2021 | 19.02B | -35.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Stella Pharma | 25.53B |
| Japan Tissue Engineering | 24.98B |
| AnGes | 22.95B |
| RaQualia Pharma | 22.27B |
| StemRIM | 20.00B |
| Renascience | 19.86B |
| CanBas | 14.22B |
| Immuno-Biological Laboratories | 13.73B |